Friday June 23rd 2017

Archive for September, 2014

National MS Society Invests Nearly $19 Million in New Research to Stop Multiple Sclerosis, Restore F

National MS Society Invests Nearly $19 Million in New Research to Stop Multiple Sclerosis, Restore F

/About-the-Society/News/National-MS-Society-Invests-Nearly-$19-Million-in [Read More]

Neurodegeneration: Active astrocytes drive inflammation

Neurodegeneration: Active astrocytes drive inflammation

Nature Reviews Neuroscience 15, 698 (2014). doi:10.1038/nrn3844 Author: Katherine Whalley Astrocyte activation has been linked to neurodegeneration in conditions such as multiple sclerosis (MS); however, the molecular mechanisms involved are unclear. The authors found that [Read More]

Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model

Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model

The definition of secondary progressive multiple sclerosis (SPMS) has always been imprecise and subjective, even using the most accepted recommendations for determining the onset of this critical phase of relapse onset multiple sclerosis (RMS) . A systematic scoring system [Read More]

 Page 1 of 102  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]